Diagnosis of Huntington's disease via sequential 18F-DOPA and 18F-FDG PET/MRI.
Erstdiagnose eines Morbus Huntington mittels 18F-DOPA und 18F-FDG PET/MRI.
Journal
Nuklearmedizin. Nuclear medicine
ISSN: 2567-6407
Titre abrégé: Nuklearmedizin
Pays: Germany
ID NLM: 7609387
Informations de publication
Date de publication:
Sep 2019
Sep 2019
Historique:
pubmed:
26
7
2019
medline:
28
4
2020
entrez:
26
7
2019
Statut:
ppublish
Résumé
Cases of rare movement disorders like Huntington's disease (HD) are not easy to diagnose, especially when occurring sporadically, without documented family history. In HD patients, MRI scans commonly feature atrophy of the striatum and reduced volume of white matter. But if morphological findings remain unspecific, functional PET imaging could provide valuable information to further clarify diagnosis. We present a case report of a 56-year-old woman suffering from mild hypokinetic-rigid syndrome and depression, suspicious of Parkinson's disease, who was referred to
Substances chimiques
Fluorodeoxyglucose F18
0Z5B2CJX4D
fluorodopa F 18
2C598205QX
Dihydroxyphenylalanine
63-84-3
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
403-404Informations de copyright
Georg Thieme Verlag KG Stuttgart · New York.
Déclaration de conflit d'intérêts
The authors declare that they have no conflict of interest.